Đang chuẩn bị liên kết để tải về tài liệu:
Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
To assess construct validity and responsiveness of the Expanded Prostate Cancer Index Composite Instrument (EPIC-26) relative to the Short-Form Six-Dimension (SF-6D) and Assessment of Quality of Life 6-Dimension (AQoL-6D) in patients following treatment for prostate cancer. |